dr. matulonis on the nova trial of niraparib maintenance therapy in ovarian cancer
Published 7 years ago • 285 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
0:58
dr. matulonis on individualized dosing of niraparib in ovarian cancer
-
1:37
dr. matulonis discusses maintenance in ovarian cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
1:48
niraparib maintenance therapy in ovarian cancer
-
5:13
treating ovarian cancer with niraparib: the nova trial
-
6:25
niraparib maintenance therapy for ovarian cancer
-
1:02:57
peri-operative therapy in urothelial carcinoma: uromigos live 2024
-
6:31
prima: frontline niraparib maintenance therapy in ovarian cancer
-
1:44
dr. matulonis on the current treatment landscape in ovarian cancer
-
1:25
dr. matulonis on final data from keynote-100 in recurrent ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
1:17
dr. matulonis on the use of immunotherapy in recurrent ovarian cancer
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
1:54
dr. matulonis on toxicities with olaparib for patients with ovarian cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
0:54
dr. ursula matulonis on phase iii trials examining cediranib plus olaparib in ovarian cancer
-
3:08
ovarian cancer: optimizing treatment with niraparib